Insulin Aspart powder Cas No.116094-23-6
Product source: Preparation by genetic engineering recombinant technology
Content specification: ≥ 95%
CAS NO：116094-23-6
Detection method: HPLC
Active ingredient: Insulin Aspart
Molecular weight: 5825.8 Da
Product Description: White Powder
Product use: Preparation of quick acting insulin injection solution
Product packaging: Common packaging capacity 1g/bottle, 5g/bottle (customized according to customer needs)
Product storage: Unopened: -20 ° C ± 5 ° C frozen storage (long-term stability);
After opening: Refrigerate at 2-8 ° C and use within 7 days (avoid repeated freezing and thawing)
Shelf life: Frozen state (-20 ° C): 36 months (subject to actual stability study data);
Refrigerated state (2-8 ° C): 12 months (short-term transportation allowed).
Products Description
Comprehensive Overview of High-Purity Insulin Aspart Powder
Insulin Aspart Powder is a biosynthesized ultrashort-acting human insulin analog formed by replacing the proline at position 28 of the B chain of human insulin with aspartic acid.
After subcutaneous injection of Insulin Aspart Powder, it is rapidly absorbed, with an onset time of only 5-15 minutes, reaching its maximum biological effect at 1-1.5 hours, and lasting for only 4-5 hours. In patients with type 1 diabetes, the application of Insulin Aspart Powder for the treatment of glycated hemoglobin reduction is significantly more effective than conventional short-acting insulin therapy.
Patients with type 1 diabetes who use insulin lispro have similar reductions in glycosylated hemoglobin levels and hypoglycemic events compared to those using human insulin. Insulin lispro significantly reduces postprandial blood glucose levels and significantly lowers the risk of hypoglycemia, especially nocturnal hypoglycemia, in the treatment of both type 1 and type 2 diabetes.
Products Advantages
Instant insulin, with rapid onset of action. It begins to take effect within 15 minutes of administration.
Produced by biotechnology, it complies with GMP standards and has the same quality as the original research product.
Core efficacy of the product
Xi'an Tihealth Biotechnology Co., Ltd
The core efficacy description of high-purity Insulin Aspart Powder raw material is strictly based on its biological activity and clinical application facts:
Can quickly reduce blood sugar
Can reduce the risk of hypoglycemia
It can also flexibly adapt to various treatment scenarios
Products Application
Powerful Solutions For Business Growth
Used for the treatment of type 1 diabetes
Used for the treatment of type 2 diabetes
Hot Tags: Insulin Aspart powder Cas No.116094-23-6, China Insulin Aspart powder Cas No.116094-23-6 manufacturers, suppliers, factory
You Might Also Like
Send Inquiry